Lantheus Holdings (LNTH) Cash & Current Investments (2014 - 2026)

Lantheus Holdings' (LNTH) quarterly Cash & Current Investments came in at $498.6 million in Q1 2026, down 46.88% year-on-year from $938.5 million in Q1 2025, and up 38.83% on a QoQ basis from $359.1 million in Q4 2025.

Lantheus Holdings (LNTH) Cash & Current Investments (2014 - 2026) Analysis & Trends

Lantheus Holdings (LNTH) has 13 years of Cash & Current Investments data on file, last reported at $498.6 million in Q1 2026.

  • On a quarterly basis, Cash & Current Investments fell 46.88% year-over-year to $498.6 million in Q1 2026; TTM through Mar 2026 was $498.6 million, a 46.88% decrease from a year earlier, with the FY2025 full-year figure at $359.1 million, down 60.66% from the prior year.
  • Cash & Current Investments for Q1 2026 stood at $498.6 million, up from $359.1 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for LNTH reached as high as $938.5 million in Q1 2025 and fell as low as $105.4 million in Q1 2022.
  • Historically, Cash & Current Investments has averaged $546.5 million across 5 years, with a median of $498.6 million in 2026.
  • Across the five-year window, Cash & Current Investments surged 346.93% in 2023 and tumbled 60.66% in 2025, its largest moves.
  • Year by year, Cash & Current Investments stood at $415.7 million in 2022, then jumped by 71.7% to $713.7 million in 2023, then advanced by 27.91% to $912.8 million in 2024, then tumbled by 60.66% to $359.1 million in 2025, then soared by 38.83% to $498.6 million in 2026.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $498.6 million in Q1 2026, $359.1 million in Q4 2025, and $382.0 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 1.86 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 3.74 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 1.94 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 4.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 2.15 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 33.59 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.80 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 1.32 Bn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 428.00 Mn
10 Lantheus Holdings 6.72 Bn 6.22 Bn 230.92 Mn 498.58 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 498.58 Mn
Dec 31, 2025 359.12 Mn
Sep 30, 2025 382.01 Mn
Jun 30, 2025 695.57 Mn
Mar 31, 2025 938.53 Mn
Dec 31, 2024 912.81 Mn
Sep 30, 2024 866.39 Mn
Jun 30, 2024 757.02 Mn
Mar 31, 2024 718.28 Mn
Dec 31, 2023 713.66 Mn
Sep 30, 2023 614.13 Mn
Jun 30, 2023 414.08 Mn
Mar 31, 2023 470.86 Mn
Dec 31, 2022 415.65 Mn
Sep 30, 2022 257.26 Mn
Jun 30, 2022 171.43 Mn
Mar 31, 2022 105.36 Mn
Dec 31, 2021 98.51 Mn
Sep 30, 2021 91.48 Mn
Jun 30, 2021 91.50 Mn